Go Pro

Braskem (BAK) Competitors

Braskem logo
$2.36 -0.11 (-4.27%)
Closing price 07/20/2026 03:59 PM Eastern
Extended Trading
$2.37 +0.02 (+0.64%)
As of 07/20/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BAK vs. MEOH, AVNT, CC, NGVT, and ECVT

Should you buy Braskem stock or one of its competitors? MarketBeat compares Braskem with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Braskem include Methanex (MEOH), Avient (AVNT), Chemours (CC), Ingevity (NGVT), and Ecovyst (ECVT). These companies are all part of the "chemicals" industry.

How does Braskem compare to Methanex?

Methanex (NASDAQ:MEOH) and Braskem (NYSE:BAK) are both chemicals companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, media sentiment, valuation, earnings and profitability.

Methanex currently has a consensus price target of $69.00, indicating a potential upside of 26.14%. Braskem has a consensus price target of $3.40, indicating a potential upside of 44.37%. Given Braskem's higher possible upside, analysts plainly believe Braskem is more favorable than Methanex.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Methanex
1 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.45
Braskem
5 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.38

73.5% of Methanex shares are held by institutional investors. 1.0% of Methanex shares are held by company insiders. Comparatively, 0.0% of Braskem shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Methanex has a beta of 0.6, indicating that its stock price is 40% less volatile than the broader market. Comparatively, Braskem has a beta of 1.61, indicating that its stock price is 61% more volatile than the broader market.

Methanex has a net margin of -1.25% compared to Braskem's net margin of -13.72%. Methanex's return on equity of 2.96% beat Braskem's return on equity.

Company Net Margins Return on Equity Return on Assets
Methanex-1.25% 2.96% 1.12%
Braskem -13.72%-23.17%2.72%

In the previous week, Methanex had 22 more articles in the media than Braskem. MarketBeat recorded 24 mentions for Methanex and 2 mentions for Braskem. Methanex's average media sentiment score of 0.68 beat Braskem's score of 0.00 indicating that Methanex is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Methanex
8 Very Positive mention(s)
2 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Braskem
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Methanex has higher earnings, but lower revenue than Braskem. Methanex is trading at a lower price-to-earnings ratio than Braskem, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Methanex$3.59B1.18$79.88M-$0.49N/A
Braskem$12.66B0.07-$1.77B-$4.22N/A

Summary

Methanex beats Braskem on 11 of the 16 factors compared between the two stocks.

How does Braskem compare to Avient?

Braskem (NYSE:BAK) and Avient (NYSE:AVNT) are both chemicals companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings, media sentiment and analyst recommendations.

In the previous week, Avient had 3 more articles in the media than Braskem. MarketBeat recorded 5 mentions for Avient and 2 mentions for Braskem. Avient's average media sentiment score of 0.97 beat Braskem's score of 0.00 indicating that Avient is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Braskem
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Avient
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Avient has a net margin of 4.81% compared to Braskem's net margin of -13.72%. Avient's return on equity of 11.11% beat Braskem's return on equity.

Company Net Margins Return on Equity Return on Assets
Braskem-13.72% -23.17% 2.72%
Avient 4.81%11.11%4.40%

Avient has lower revenue, but higher earnings than Braskem. Braskem is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Braskem$12.66B0.07-$1.77B-$4.22N/A
Avient$3.26B1.02$81.90M$1.7220.99

Braskem presently has a consensus price target of $3.40, indicating a potential upside of 44.37%. Avient has a consensus price target of $45.71, indicating a potential upside of 26.62%. Given Braskem's higher probable upside, equities research analysts plainly believe Braskem is more favorable than Avient.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Braskem
5 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.38
Avient
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43

Braskem has a beta of 1.61, meaning that its stock price is 61% more volatile than the broader market. Comparatively, Avient has a beta of 1.27, meaning that its stock price is 27% more volatile than the broader market.

95.5% of Avient shares are owned by institutional investors. 0.0% of Braskem shares are owned by company insiders. Comparatively, 0.9% of Avient shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Avient beats Braskem on 13 of the 16 factors compared between the two stocks.

How does Braskem compare to Chemours?

Braskem (NYSE:BAK) and Chemours (NYSE:CC) are both chemicals companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.

Chemours has lower revenue, but higher earnings than Braskem. Chemours is trading at a lower price-to-earnings ratio than Braskem, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Braskem$12.66B0.07-$1.77B-$4.22N/A
Chemours$5.81B0.45-$386M-$2.64N/A

Braskem has a beta of 1.61, meaning that its share price is 61% more volatile than the broader market. Comparatively, Chemours has a beta of 1.41, meaning that its share price is 41% more volatile than the broader market.

In the previous week, Chemours had 3 more articles in the media than Braskem. MarketBeat recorded 5 mentions for Chemours and 2 mentions for Braskem. Chemours' average media sentiment score of 0.60 beat Braskem's score of 0.00 indicating that Chemours is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Braskem
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Chemours
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Chemours has a net margin of -6.82% compared to Braskem's net margin of -13.72%. Chemours' return on equity of 52.49% beat Braskem's return on equity.

Company Net Margins Return on Equity Return on Assets
Braskem-13.72% -23.17% 2.72%
Chemours -6.82%52.49%1.78%

Braskem currently has a consensus target price of $3.40, indicating a potential upside of 44.37%. Chemours has a consensus target price of $24.10, indicating a potential upside of 40.14%. Given Braskem's higher possible upside, equities research analysts clearly believe Braskem is more favorable than Chemours.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Braskem
5 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.38
Chemours
1 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.42

76.3% of Chemours shares are owned by institutional investors. 0.0% of Braskem shares are owned by insiders. Comparatively, 0.9% of Chemours shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Chemours beats Braskem on 11 of the 16 factors compared between the two stocks.

How does Braskem compare to Ingevity?

Braskem (NYSE:BAK) and Ingevity (NYSE:NGVT) are both chemicals companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations, risk and media sentiment.

Ingevity has lower revenue, but higher earnings than Braskem. Ingevity is trading at a lower price-to-earnings ratio than Braskem, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Braskem$12.66B0.07-$1.77B-$4.22N/A
Ingevity$1.17B2.24-$167.10M-$3.55N/A

In the previous week, Ingevity had 1 more articles in the media than Braskem. MarketBeat recorded 3 mentions for Ingevity and 2 mentions for Braskem. Ingevity's average media sentiment score of 1.11 beat Braskem's score of 0.00 indicating that Ingevity is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Braskem
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Ingevity
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Braskem has a beta of 1.61, indicating that its stock price is 61% more volatile than the broader market. Comparatively, Ingevity has a beta of 1.16, indicating that its stock price is 16% more volatile than the broader market.

Ingevity has a net margin of -10.55% compared to Braskem's net margin of -13.72%. Ingevity's return on equity of 207.82% beat Braskem's return on equity.

Company Net Margins Return on Equity Return on Assets
Braskem-13.72% -23.17% 2.72%
Ingevity -10.55%207.82%9.70%

91.6% of Ingevity shares are owned by institutional investors. 0.0% of Braskem shares are owned by insiders. Comparatively, 0.9% of Ingevity shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Braskem currently has a consensus price target of $3.40, indicating a potential upside of 44.37%. Ingevity has a consensus price target of $80.00, indicating a potential upside of 6.59%. Given Braskem's higher probable upside, research analysts plainly believe Braskem is more favorable than Ingevity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Braskem
5 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.38
Ingevity
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20

Summary

Ingevity beats Braskem on 12 of the 16 factors compared between the two stocks.

How does Braskem compare to Ecovyst?

Braskem (NYSE:BAK) and Ecovyst (NYSE:ECVT) are both small-cap chemicals companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.

Braskem has a beta of 1.61, indicating that its share price is 61% more volatile than the broader market. Comparatively, Ecovyst has a beta of 1.1, indicating that its share price is 10% more volatile than the broader market.

86.7% of Ecovyst shares are owned by institutional investors. 0.0% of Braskem shares are owned by company insiders. Comparatively, 1.8% of Ecovyst shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Ecovyst has lower revenue, but higher earnings than Braskem. Ecovyst is trading at a lower price-to-earnings ratio than Braskem, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Braskem$12.66B0.07-$1.77B-$4.22N/A
Ecovyst$723.50M1.88-$71.13M-$0.55N/A

In the previous week, Ecovyst had 2 more articles in the media than Braskem. MarketBeat recorded 4 mentions for Ecovyst and 2 mentions for Braskem. Ecovyst's average media sentiment score of 0.72 beat Braskem's score of 0.00 indicating that Ecovyst is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Braskem
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Ecovyst
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Braskem presently has a consensus target price of $3.40, indicating a potential upside of 44.37%. Ecovyst has a consensus target price of $13.90, indicating a potential upside of 11.99%. Given Braskem's higher possible upside, analysts plainly believe Braskem is more favorable than Ecovyst.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Braskem
5 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.38
Ecovyst
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.71

Ecovyst has a net margin of -7.71% compared to Braskem's net margin of -13.72%. Ecovyst's return on equity of 11.58% beat Braskem's return on equity.

Company Net Margins Return on Equity Return on Assets
Braskem-13.72% -23.17% 2.72%
Ecovyst -7.71%11.58%4.76%

Summary

Ecovyst beats Braskem on 13 of the 17 factors compared between the two stocks.

Get Braskem News Delivered to You Automatically

Sign up to receive the latest news and ratings for BAK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BAK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BAK vs. The Competition

MetricBraskemOIL IndustryEnergy SectorNYSE Exchange
Market Cap$980.57M$98.09B$10.10B$23.42B
Dividend YieldN/A3.32%11.32%4.16%
P/E Ratio-0.5615.6019.2330.65
Price / Sales0.071.76397.6320.36
Price / Cash1.437.0136.7418.81
Price / Book-0.321.474.084.74
Net Income-$1.77B$4.67B$4.24B$1.07B
7 Day Performance-12.94%-0.27%-0.41%-0.42%
1 Month Performance-19.76%0.40%-0.91%0.69%
1 Year Performance-23.16%36.86%29.42%16.45%

Braskem Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BAK
Braskem
2.9613 of 5 stars
$2.36
-4.3%
$3.40
+44.4%
-23.0%$980.57M$12.66BN/A8,233
MEOH
Methanex
3.6977 of 5 stars
$53.39
+4.8%
$68.78
+28.8%
+62.2%$4.16B$3.59BN/A1,649
AVNT
Avient
4.3549 of 5 stars
$35.48
-0.3%
$45.71
+28.8%
+11.1%$3.25B$3.26B20.599,000
CC
Chemours
4.1805 of 5 stars
$18.61
+2.7%
$24.10
+29.5%
+26.7%$2.80B$5.81BN/A5,700
NGVT
Ingevity
2.0708 of 5 stars
$71.79
+0.3%
$80.00
+11.4%
+62.6%$2.50B$1.17BN/A1,500

Related Companies and Tools


This page (NYSE:BAK) was last updated on 7/21/2026 by MarketBeat.com Staff.
From Our Partners